| ACOR Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ACOR shares outstanding history going back to 2/19/2010:
Also see: ACOR Market Cap History ACOR YTD Return |
ACOR Shares Outstanding History — Acorda Therapeutics Share Count Over Time
As of 3/27/2024 Acorda Therapeutics has 1.24 million ACOR shares outstanding. Investors often track the ACOR shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ACOR share count trends over time, with 56 historical shares outstanding datapoints presented, dating back to 2/19/2010.
| ACOR Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACOR Historical Shares Outstanding: +10.14% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACOR Stock Price Chart |
| About Acorda Therapeutics Inc |
| Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Co. markets Inbrija (levodopa inhalation powder), which is approved for intermittent treatment of episodic motor fluctuations, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija utilizes Co.'s ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Co. also markets Ampyra (dalfampridine) extended release tablets, 10 mg for improving walking in patients with multiple sclerosis. Ampyra is marketed as Fampyra outside the U.S. We show 56 historical shares outstanding datapoints in our coverage of ACOR's shares outstanding history. Understanding the changing numbers of ACOR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACOR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACOR by allowing them to research ACOR shares outstanding history as well as any other stock in our coverage universe. |
| ACOR Current Stock Quote |
Quotes delayed 20 minutes  Free ACOR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ACOR Share Performance |
| Shares Outstanding Peers |
| Acorda Therapeutics (ACOR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ACRS Shares Outstanding History ACRV Shares Outstanding History ACRX Shares Outstanding History ACST Shares Outstanding History ACTU Shares Outstanding History ACXP Shares Outstanding History ADGI Shares Outstanding History ADIL Shares Outstanding History ADMA Shares Outstanding History ADMP Shares Outstanding History More Healthcare companies » |
ACOR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
